Patients with sickle cell disease were successfully treated with hydroxyurea, incrementally increased doses of intravenous erythropoietin, and oral iron supplements | Zendy

AI Assistant Blog Pricing

Patients with sickle cell disease were successfully treated with hydroxyurea, incrementally increased doses of intravenous erythropoietin, and oral iron supplements

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.